Opportunity in the Sell-Off: 10 S&P 500 Stocks Down 20% That Analysts Are Bullish On

Financial Service, Life Science, Technology

What Will Drive Regeneron Pharmaceuticals in the Next Decade?

Life Science

Gilead to Acquire Arcellx for Up to $7.8 Billion, Doubling Down on Next-Generation CAR-T Therapy

Life Science

Aiming at a Billion-Dollar Market, Pfizer Doubles Down on Obesity Therapies in China

Life Science

Forget the S&P 500: Three Value ETFs Hitting New Highs Right Now

Consumer Goods, Financial Service, Life Science

This Weight-Loss Drug ‘Dark Horse’ Could Take You for a Ride

Life Science

Novo Nordisk Shares Plunge 16% as CagriSema Lags Behind Lilly’s Drug in Key Trial

Life Science

Forget AI and Weight-Loss Drugs: Why Vertex Pharmaceuticals Is the Silent Compounder You Need

Life Science

Will One Comment from Eli Lilly Turn Around Novo Nordisk’s Stock?

Life Science

Is the Current US Stock Market Lacking Bargains? These Two High-Yield Dividend Stocks Are Worth Watching

Energy, Life Science

Searching for the Next ‘Star Stock’? Wall Street Recommends These Two Biotech Stocks

Life Science

Can Viking Therapeutics Really Soar 300%? Why Wall Street Is Betting Big on This Biotech Stock

Life Science

ImmunityBio Soars Over 40% as European Commission Approves Bladder Cancer Drug Anktiva

Life Science

A Once-in-a-Decade Buying Opportunity Emerges! Three Stocks Not to Be Missed

Life Science

Why Alnylam Soared 6%: One Analyst Says the Biotech’s Growth Story Is Just Getting Started

Life Science